These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 32522871)
21. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014 [TBL] [Abstract][Full Text] [Related]
22. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection. Price AM; Messinger JE; Luftig MA J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124 [TBL] [Abstract][Full Text] [Related]
23. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells. Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904 [TBL] [Abstract][Full Text] [Related]
24. Mouse model for acute Epstein-Barr virus infection. Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754 [TBL] [Abstract][Full Text] [Related]
25. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival. Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277 [TBL] [Abstract][Full Text] [Related]
26. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104 [TBL] [Abstract][Full Text] [Related]
27. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607 [TBL] [Abstract][Full Text] [Related]
29. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells. Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646 [TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth. Tobollik S; Meyer L; Buettner M; Klemmer S; Kempkes B; Kremmer E; Niedobitek G; Jungnickel B Blood; 2006 Dec; 108(12):3859-64. PubMed ID: 16882707 [TBL] [Abstract][Full Text] [Related]
31. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV J Virol; 2004 Dec; 78(24):13891-900. PubMed ID: 15564497 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416 [TBL] [Abstract][Full Text] [Related]
33. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. Wasil LR; Wei L; Chang C; Lan L; Shair KH J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552 [TBL] [Abstract][Full Text] [Related]
34. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. Ma SD; Hegde S; Young KH; Sullivan R; Rajesh D; Zhou Y; Jankowska-Gan E; Burlingham WJ; Sun X; Gulley ML; Tang W; Gumperz JE; Kenney SC J Virol; 2011 Jan; 85(1):165-77. PubMed ID: 20980506 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection. Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849 [TBL] [Abstract][Full Text] [Related]
37. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells. Allday MJ; Bazot Q; White RE Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the Bazot Q; Paschos K; Allday MJ J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247 [TBL] [Abstract][Full Text] [Related]
39. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL. Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452 [TBL] [Abstract][Full Text] [Related]
40. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity. Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]